Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naveen Krishnegowda

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Blood Cells, Molecules & Diseases|February 6, 2004
Knockdown of prothrombin in zebrafishKenneth Day, Naveen Krishnegowda, Pudur Jagadeeswaran
Progress in Molecular Biology and Translational Science|November 4, 2017
Therapeutic Use of Estrogen Receptor β Agonists in Prevention and Treatment of Endocrine Therapy Resistant Breast Cancers: Observations From Preclinical ModelsKumaraguruparan Ramasamy, Cathy Samayoa, Naveen Krishnegowda, et al.
The Journal of Surgical Research|October 25, 2006
Compensatory increases in Her-2/neu activation in response to EGFR tyrosine kinase inhibition in colon cancer cell linesPeter A Learn, Naveen Krishnegowda, Jose Talamantez, et al.
Biomedicines|February 25, 2023
Infusion of Some but Not All Types of Human Perinatal Stromal Cells Prevent Organ Fibrosis in a Humanized Graft versus Host Disease Murine ModelRamon E Coronado, Elena Stavenschi Toth, Maria Somaraki-Cormier, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|July 15, 2015
Impaired Development of Early Endometriotic Lesions in CD44 Knockout MiceJennifer F Knudtson, Rajeshwar R Tekmal, Marlen Tellez Santos, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Blood Cells, Molecules & Diseases|February 6, 2004
Knockdown of prothrombin in zebrafishKenneth Day, Naveen Krishnegowda, Pudur Jagadeeswaran
Progress in Molecular Biology and Translational Science|November 4, 2017
Therapeutic Use of Estrogen Receptor β Agonists in Prevention and Treatment of Endocrine Therapy Resistant Breast Cancers: Observations From Preclinical ModelsKumaraguruparan Ramasamy, Cathy Samayoa, Naveen Krishnegowda, et al.
The Journal of Surgical Research|October 25, 2006
Compensatory increases in Her-2/neu activation in response to EGFR tyrosine kinase inhibition in colon cancer cell linesPeter A Learn, Naveen Krishnegowda, Jose Talamantez, et al.
Biomedicines|February 25, 2023
Infusion of Some but Not All Types of Human Perinatal Stromal Cells Prevent Organ Fibrosis in a Humanized Graft versus Host Disease Murine ModelRamon E Coronado, Elena Stavenschi Toth, Maria Somaraki-Cormier, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|July 15, 2015
Impaired Development of Early Endometriotic Lesions in CD44 Knockout MiceJennifer F Knudtson, Rajeshwar R Tekmal, Marlen Tellez Santos, et al.
Pageof 1